New mandatory reporting rules aim to curb medical device injuries

Australia has introduced significant regulatory changes to improve the safety of medical devices following long-standing concerns about patient harm. As of March 2026, public and private hospitals, along with day-hospital facilities, are legally required to report adverse events involving high-risk medical devices to the Therapeutic Goods Administration. This shift marks a move away from voluntary systems toward a mandatory framework designed to help authorities identify safety risks more quickly and intervene before more patients are affected. The new requirements specifically target Class III medical devices and high-risk in vitro diagnostic tools, such as pacemakers, prosthetic heart valves, and hip or knee implants. By mandating the reporting of deaths or serious health deterioration, the government aims to create a more transparent and accountable system. These reforms follow years of international and local scrutiny regarding the medical device industry, which highlighted gaps in how injuries were tracked and how quickly dangerous products were removed from the market. While the primary goal is to enhance patient safety, the implementation of these rules also places new administrative responsibilities on healthcare facilities. Hospitals must now ensure they have robust systems in place to capture and submit detailed incident data, including device identifiers and the nature of the injury. As these regulations take effect, the focus remains on whether this increased flow of information will lead to faster product recalls and better clinical outcomes for Australians relying on these life-saving technologies.